Non-enzymatic posttranslational modifications of bovine serum albumin by oxo-compounds investigated by chromatographic and electrophoretic methods

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 815, Issue 1-2, 2005, Pages 315-331

  Mikulíková, Kateřina ^a,b   Mikšík, Ivan ^a   Deyl, Zdeněk ^a  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Bovine serum albumin; Non enzymatic posttranslational modifications; Oxo compounds

Indexed keywords

ALDEHYDES; AMINO ACIDS; BODY FLUIDS; DERIVATIVES; ELECTROPHORESIS; GLUCOSE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

BOVINE SERUM ALBUMIN (BSA); CAPILLARY ZONE ELECTROPHORESIS (CZE); DIODE ARRAYS; TRYPTIC CLEAVAGE;

ENZYMES;

ANAZOLENE SODIUM; BOVINE SERUM ALBUMIN; GLUCOSE; GLUTARALDEHYDE; GLYOXAL; RIBOSE;

AMINO ACID ANALYSIS; ARTICLE; CAPILLARY ZONE ELECTROPHORESIS; CROSS LINKING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PEPTIDE MAPPING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PROCESSING; STAINING; ULTRAVIOLET SPECTROPHOTOMETRY;

ALDEHYDES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROPHORESIS, CAPILLARY; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GLUCOSE; GLUTARAL; GLYOXAL; KETONES; MASS SPECTROMETRY; PEPTIDE FRAGMENTS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RIBOSE; SERUM ALBUMIN, BOVINE; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROPHOTOMETRY, ULTRAVIOLET; TRYPSIN;

BOVINAE;

EID: 12344331559     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2004.10.062     Document Type: Article

References (23)

1. I. Mikšík, and Z. Deyl Post-translational non-enzymatic modification of proteins II. Separation of selected protein species after glycation and other carbonyl-mediated modifications J. Chromatogr. B 699 1997 311
2. Z. Deyl, and I. Mikšík Post-translational non-enzymatic modification of proteins I. Chromatography of marker adducts with special emphasis to glycation reactions J. Chromatogr. B 699 1997 287
3. L.C. Maillard Action des acides amines sur les sucres; formation des melanoidines par voie methodique C. R. Hebd. Acad. Sci. Ser. 2 154 1912 S1554
4. V.M. Monnier Intervention against the Maillard reaction in vivo Arch. Biochem. Biophys. 419 2003 1
5. A.W. Stitt, A.J. Jenkins, and M.E. Cooper Advanced glycation end products and diabetic complications Expert Opin. Invest. Drugs 11 2002 1205
6. D.R. Sell, R.H. Nagaraj, S.K. Grandhee, P. Odetti, A. Lapolla, J. Fogarty, and V.M. Monnier Pentosidine-A molecular marker for the cumulative damage to proteins in diabetes, aging, and uremia Diabetes/Metabolism Rev. 7 1991 239
7. J.A. Dunn, J.S. Patrick, S.R. Thorpe, and J.W. Baynes Oxidation of glycated proteins: age-dependent accumulation of N-epsilon-(carboxymethyl)lysine in lens proteins Biochemistry 28 1989 9464
8. R. Nagai, K. Ikeda, T. Higashi, H. Sano, Y. Jinnouchi, T. Araki, and S. Horiuchi Hydroxyl radical mediates N-epsilon-(carboxymethyl)lysine formation from Amadori product Biochem. Biophys. Res. Commun. 234 1997 167
9. M.X. Fu, J.R. Requena, A.J. Jenkins, T.J. Lyons, J.W. Baynes, and S.R. Thorpe The advanced glycation end product, N-epsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions J. Biol. Chem. 271 1996 9982
10. M.A. Glomb, and V.M. Monnier Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction J. Biol. Chem. 270 1995 10017
11. K.J. Wells-Knecht, D.V. Zyzak, J.E. Litchfield, S.R. Thorpe, and J.W. Baynes Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose Biochemistry 21 1995 3702
12. F. Ledl, J. Beck, M. Sengl, H. Osiander, S. Estendorfer, T. Severin, and B. Huber J.W. Baynes V.M. Monnier The Maillard Reaction in Aging, Diabetes and Nutrition 1988 Alan R. Liss New York 23
13. J.W. Baynes, N.G. Watkins, C.I. Fisher, C.J. Hull, J.S. Patrick, M.U. Ahmed, J.A. Dunn, and S.R. Thorpe J.W. Baynes V.M. Monnier The Maillard Reaction in Aging, Diabetes and Nutrition 1988 Alan R. Liss New York 43
14. M. Brownlee, H. Vlassara, and A. Cerami Ann. Intern. Med. 101 1984 527
15. M.P. Cohen Diabetes and Protein Glycation 1996 J.C. Press p. 107
16. B.K. Martin Potencial effect of the plasma proteins on drug distribution Nature 207 1965 274 (London)
17. J.R. Gillette Overview of drug-protein binding Ann. N. Y. Acad. Sci. 226 1973 6
18. K.J. Fehske, W.E. Müller, and U. Wollert The location of drug-binding sites in human-serum albumin Biochem. Pharmacol. 30 1981 681
19. K.J. Fehske, W.E. Müller, and U. Wollert A highly reactive tyrosine residue as part of the indole and benzodiazepine binding site of human serum albumin Biochim. Biophys. Acta 577 1979 346
20. R. Broderson, T. Sjödin, and I. Sjöholm Independent binding of ligands to human serum albumin J. Biol. Chem. 252 1977 5067
21. W.E. Müller, and U. Wollert Pharmacology 19 1979 59
22. D.C. Carter, X. He, S.H. Munson, P.D. Twigg, K.L. Gernert, M.B. Broom, and T.Y. Miller Science 244 1989 1195
23. Y. Wada Primary sequence and glycation at lysine-548 of bovine serum albumin J. Mass Spectrom. 31 1996 263